JD Health International Inc.
6618.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$115.86B
Close$
$68.05
76.5% upside
Current Fair Value
76.5% upsideUndervalued by 76.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $115.86 Billion |
|---|---|
| Enterprise Value | $96.86 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $1.68 |
| Beta | 1.19 |
| Outstanding Shares | 3,177,630,000 |
Return
| Return on Equity | 17.64% |
|---|---|
| Return on Assets | 12.88% |
| Return on Invested Capital | 17.18% |
Valuation & Multiples
| P/E Ratio | 16 |
|---|---|
| PEG | 51.76 |
| Price to Sales | 0.88 |
| Price to Book Ratio | 2.03 |
| Enterprise Value to Revenue | 0.68 |
| Enterprise Value to EBIT | 9.01 |
| Enterprise Value to Net Income | 8 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$1.35
Average shareholder expectationRevenue Estimate
$47.66 B
Average shareholder expectationNext Earnings Call
Expected Date
March 29, 2027
EPS Estimate
$1.13
Average shareholder expectationRevenue Estimate
$52.86 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About JD Health International Inc.
6,018 employees
CEO: Dong Cao JD Health International Inc., functioning as an investment holding entity, runs an expansive digital healthcare platform across the People's Republic of China. The company supplies a diverse range of pharmaceutical and wellness products,...